Adeno-Associated Virus (AAV) - Based Gene Therapies for Retinal Diseases: Where are We?
Ontology highlight
ABSTRACT: Abstract Owing to their small size and safety profiles, adeno-associated viruses (AAVs) have become the vector of choice for gene therapy applications in the retina. In addition to the naturally occurring AAVs, several engineered variants with enhanced properties are being developed for experimental and therapeutic applications. Nonetheless, there are still some challenges impeding successful application of AAVs for a broader range of retinal gene therapies. The small size of AAV particles ensures efficient tissue transduction but also limits the packaging capacity to a few kilobases. Further, AAV’s ability to cross retinal barriers is still an obstacle to pan-retinal transduction of the outer retina with tolerable doses. Lastly, despite overall safety, there have been recent reports of im
SUBMITTER: Ail D
PROVIDER: S-EPMC10239239 | biostudies-literature | 2023 Jan
REPOSITORIES: biostudies-literature
ACCESS DATA